Randomized phase I pharmacokinetic study of ipilimumab with or without one of two different chemotherapy regimens in patients with untreated advanced melanoma

od Weber, Jeffrey, Hamid, Omid, Amin, Asim, O’Day, Steven, Masson, Eric, Goldberg, Stacie M., Williams, Daphne, Parker, Susan M., Chasalow, Scott D., Alaparthy, Suresh, Wolchok, Jedd D.
Izdano 2013

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

od Brahmer, Julie R., Tykodi, Scott S., Chow, Laura Q.M., Hwu, Wen-Jen, Topalian, Suzanne L., Hwu, Patrick, Drake, Charles G., Camacho, Luis H., Kauh, John, Odunsi, Kunle, Pitot, Henry C., Hamid, Omid, Bhatia, Shailender, Martins, Renato, Eaton, Keith, Chen, Shuming, Salay, Theresa M., Alaparthy, Suresh, Grosso, Joseph F., Korman, Alan J., Parker, Susan M., Agrawal, Shruti, Goldberg, Stacie M., Pardoll, Drew M., Gupta, Ashok, Wigginton, Jon M.
Izdano 2012